arrow
P

Priscilla Y. Hsue

University of California System
H指数:65
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trials

美国启动现代抗逆转录病毒疗法的人免疫缺陷病毒感染者的高血压风险:五项临床试验血压数据的合并分析

2026-03-010
OA
Cardiovascular Risk Assessment Using the Atherosclerotic Cardiovascular Disease Risk Score Model after Continuing or Switching to a Doravirine-Based HIV Treatment Regimen

使用动脉粥样硬化性心血管疾病风险评分模型评估持续或切换至多拉韦素为基础的HIV治疗方案后的心血管风险

2026-02-010
PRE
The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial.

低剂量甲氨蝶呤对人类免疫缺陷病毒感染者动脉炎症的影响。一项双盲随机安慰剂对照的初步试验。

2025-12-110
PRE
Predicting Risk of Cardiovascular Disease Events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort

在多中心CNICS队列中,HIV感染者人群中心血管疾病事件(PREVENT)评分的准确性

AIDS
IF3.1
2025-09-040
PREAI
Prototyping and Manufacturing of Customized Over-Encapsulated Polypills for Heart Failure With Reduced Ejection Fraction in a Safety-Net Health Care System

定制化外封装复方药片在射血分数降低的心力衰竭患者中的原型设计与制造——基于安全网医疗系统

2025-05-010
PRE
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
2024-07-0317
OA
Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study

观察性队列研究中尼马曲韦治疗急性SARS-CoV-2感染与随后的长期COVID症状的关联

2024-01-0416
OA